J. B. Chemicals & Pharmaceuticals Limited
JBCHEPHARM
Pozycja w akcjach
#3883
J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai,... J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai, India, in 1976, specializes in the development, production, and global distribution of diverse pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. Among its prominent product offerings are Cilnidipine, Ranitidine, and Metronidazole. Beyond its own brands, the company extends comprehensive contract manufacturing services, covering an extensive spectrum of dosage forms such as tablets, various lozenge types, injectables, gels, creams, ointments, liquid herbal syrups, and capsules. The firm further contributes to diagnostic medicine by supplying contrast agents for advanced imaging techniques like X-ray, MRI, and ultrasound. Its therapeutic expertise encompasses a broad range of medical fields, including gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance.
Cena akcji
$26.58
Ostatnia synchronizacja: 2026-07-23
Kapitalizacja rynkowa
$4.24B
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
38.19%
Kraj
IN
Handel J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
Kategoria
Healthcare
EPS dla J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
EPS na dzień March 2026 TTM: $0.50
Według najnowszych raportów finansowych i ceny akcji firmy J. B. Chemicals & Pharmaceuticals Limited, obecny EPS (TTM) wynosi $0.50. Na koniec roku 2024 firma miała EPS w wysokości $0.43, wzrost w porównaniu do do EPS z roku 2023, który wynosił $0.32.
Historia EPS dla J. B. Chemicals & Pharmaceuticals Limited od 2005 do 2026
EPS na koniec każdego roku
| Rok | EPS | Zmień |
|---|---|---|
| 2026 (TTM) | $0.50 | -0.14% |
| 2025 | $0.50 | 16.04% |
| 2024 | $0.43 | 32.62% |
| 2023 | $0.32 | -1.80% |
| 2022 | $0.33 | -17.05% |
| 2021 | $0.40 | -13.65% |
| 2020 | $0.46 | 35.25% |
| 2019 | $0.34 | 33.94% |
| 2018 | $0.25 | -24.36% |
| 2017 | $0.33 | 15.70% |
| 2016 | $0.29 | 52.45% |
| 2015 | $0.19 | 56.65% |
| 2014 | $0.12 | -29.84% |
| 2013 | $0.17 | -89.07% |
| 2012 | $1.58 | 326.74% |
| 2011 | $0.37 | 18.09% |
| 2010 | $0.31 | 421.63% |
| 2009 | $0.06 | -55.22% |
| 2008 | $0.13 | -21.29% |
| 2007 | $0.17 | -13.10% |
| 2006 | $0.20 | 17.98% |
| 2005 | $0.17 | 0.00% |
EPS dla podobnych firm lub konkurentów
| Firma | EPS | Różnica w EPS | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 11.42% |
IN
|
